240 related articles for article (PubMed ID: 25458029)
1. [Positron emission tomography with (18)F-FDG in the evaluation of patients with rheumatoid arthritis--a systematic review].
dos Anjos DA; da Mota LM
Rev Bras Reumatol; 2014; 54(6):474-82. PubMed ID: 25458029
[TBL] [Abstract][Full Text] [Related]
2. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.
Beckers C; Jeukens X; Ribbens C; André B; Marcelis S; Leclercq P; Kaiser MJ; Foidart J; Hustinx R; Malaise MG
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):275-80. PubMed ID: 16247604
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
Wang SC; Xie Q; Lv WF
Int J Rheum Dis; 2014 Mar; 17(3):248-55. PubMed ID: 24606324
[TBL] [Abstract][Full Text] [Related]
5. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT.
Kubota K; Ito K; Morooka M; Minamimoto R; Miyata Y; Yamashita H; Takahashi Y; Mimori A
Ann N Y Acad Sci; 2011 Jun; 1228():29-38. PubMed ID: 21718320
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
Raynor WY; Jonnakuti VS; Zirakchian Zadeh M; Werner TJ; Cheng G; Zhuang H; Høilund-Carlsen PF; Alavi A; Baker JF
Int J Rheum Dis; 2019 Dec; 22(12):2191-2198. PubMed ID: 31721461
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
[TBL] [Abstract][Full Text] [Related]
9. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
10. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.
Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH
Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804
[TBL] [Abstract][Full Text] [Related]
11. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
Karapolat I; Sertpoyraz F; Oncel G; Kobak S; Yalcin M; Kumanlioglu K
Nuklearmedizin; 2013 Dec; 52(6):244-9. PubMed ID: 24081426
[TBL] [Abstract][Full Text] [Related]
12. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
[TBL] [Abstract][Full Text] [Related]
13. [18F]FDG PET/CT in rheumatoid arthritis.
Graham RN; Panagiotidis E
Q J Nucl Med Mol Imaging; 2022 Sep; 66(3):234-244. PubMed ID: 36066112
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.
Elzinga EH; van der Laken CJ; Comans EF; Lammertsma AA; Dijkmans BA; Voskuyl AE
Mol Imaging Biol; 2007; 9(6):357-60. PubMed ID: 17902022
[TBL] [Abstract][Full Text] [Related]
15. Arterial Inflammation Detected With
Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
[TBL] [Abstract][Full Text] [Related]
16. FDG PET Imaging of Extremities in Rheumatoid Arthritis.
Dhawan R; Lokitz K; Lokitz S; Caldito G; Takalkar AM
J La State Med Soc; 2016; 168(5):156-161. PubMed ID: 27797345
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of atlantoaxial involvement in patients with rheumatoid arthritis using
Noguchi A; Kurita T; Matsuzawa K
Clin Rheumatol; 2023 Jul; 42(7):1875-1884. PubMed ID: 37000282
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an
Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using ⁶⁸Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study.
Zhu Z; Yin Y; Zheng K; Li F; Chen X; Zhang F; Zhang X
Ann Rheum Dis; 2014 Jun; 73(6):1269-72. PubMed ID: 24532680
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
Kubota K; Yamashita H; Mimori A
Semin Nucl Med; 2017 Jul; 47(4):408-424. PubMed ID: 28583280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
